4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-15-067186
Chief Financial Officer acquired 15,032 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Payne Fletcher · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-08-20 | Other acquisition : show line 1 in the form | +15,032 | 15,032 | I |
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-08-20 | Other acquisition : show line 2 in the form Stock Option (Right to Buy) | +7,320 | $7.60 | 2025-01-22 | 7,320 | 7,320 | D |
| 2015-08-20 | Other acquisition : show line 3 in the form Stock Option (Right to Buy) | +2,440 | $7.60 | 2025-01-22 | 2,440 | 2,440 | D |
| 2015-08-20 | Other acquisition : show line 4 in the form Stock Option (Right to Buy) | +14,325 | $6.03 | 2025-05-08 | 14,325 | 14,325 | D |
Loading xslF345X03/doc4.xml…